Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Pollack

Showing results (81-90 of 308) with videos related to

Pageof 31
Sort By:
Acta Biomaterialia|April 29, 2008
LDI-glycerol polyurethane implants exhibit controlled release of DB-67 and anti-tumor activity in vitro against malignant gliomasWesley N Sivak, Ian F Pollack, Stéphane Petoud, et al.
Acta Biomaterialia|April 29, 2008
Catalyst-dependent drug loading of LDI-glycerol polyurethane foams leads to differing controlled release profilesWesley N Sivak, Ian F Pollack, Stéphane Petoud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial gliomaMitsugu Fujita, Xinmei Zhu, Kotaro Sasaki, et al.
Journal of Neuro-Oncology|March 8, 2008
Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomasHideho Okada, Keri L Low, Gary Kohanbash, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2015
Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell LinesEsther P Jane, Daniel R Premkumar, Jonathon M Cavaleri, et al.
Molecular Cancer Therapeutics|January 18, 2013
YM-155 potentiates the effect of ABT-737 in malignant human glioma cells via survivin and Mcl-1 downregulation in an EGFR-dependent contextEsther P Jane, Daniel R Premkumar, Joseph D DiDomenico, et al.
Neurosurgical Focus|January 2, 2010
Functional genomic analysis of glioblastoma multiforme through short interfering RNA screening: a paradigm for therapeutic developmentNikhil G Thaker, Fang Zhang, Peter R McDonald, et al.
Journal of Child Neurology|October 28, 2008
Tumors of the central nervous system: clinical aspects, molecular mechanisms, unanswered questions, and future research directionsMichael A Babcock, Felina V Kostova, Abhijit Guha, et al.
Molecular Carcinogenesis|December 15, 2017
Mitochondrial dysfunction RAD51, and Ku80 proteolysis promote apoptotic effects of Dinaciclib in Bcl-xL silenced cellsDaniel R Premkumar, Esther P Jane, Swetha Thambireddy, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 3, 2005
Individualized treatment of pediatric craniopharyngiomasA Leland Albright, Costas G Hadjipanayis, L Dade Lunsford, et al.
Pageof 31

Showing results (81-90 of 308) with videos related to

Sort By:
Pageof 31
Acta Biomaterialia|April 29, 2008
LDI-glycerol polyurethane implants exhibit controlled release of DB-67 and anti-tumor activity in vitro against malignant gliomasWesley N Sivak, Ian F Pollack, Stéphane Petoud, et al.
Acta Biomaterialia|April 29, 2008
Catalyst-dependent drug loading of LDI-glycerol polyurethane foams leads to differing controlled release profilesWesley N Sivak, Ian F Pollack, Stéphane Petoud, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2008
Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial gliomaMitsugu Fujita, Xinmei Zhu, Kotaro Sasaki, et al.
Journal of Neuro-Oncology|March 8, 2008
Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomasHideho Okada, Keri L Low, Gary Kohanbash, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 21, 2015
Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell LinesEsther P Jane, Daniel R Premkumar, Jonathon M Cavaleri, et al.
Molecular Cancer Therapeutics|January 18, 2013
YM-155 potentiates the effect of ABT-737 in malignant human glioma cells via survivin and Mcl-1 downregulation in an EGFR-dependent contextEsther P Jane, Daniel R Premkumar, Joseph D DiDomenico, et al.
Neurosurgical Focus|January 2, 2010
Functional genomic analysis of glioblastoma multiforme through short interfering RNA screening: a paradigm for therapeutic developmentNikhil G Thaker, Fang Zhang, Peter R McDonald, et al.
Journal of Child Neurology|October 28, 2008
Tumors of the central nervous system: clinical aspects, molecular mechanisms, unanswered questions, and future research directionsMichael A Babcock, Felina V Kostova, Abhijit Guha, et al.
Molecular Carcinogenesis|December 15, 2017
Mitochondrial dysfunction RAD51, and Ku80 proteolysis promote apoptotic effects of Dinaciclib in Bcl-xL silenced cellsDaniel R Premkumar, Esther P Jane, Swetha Thambireddy, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|June 3, 2005
Individualized treatment of pediatric craniopharyngiomasA Leland Albright, Costas G Hadjipanayis, L Dade Lunsford, et al.
Pageof 31